Sign in
Taking people in United StatesNo phase

Electrical muscle stimulation exercise studied in adults with myasthenia gravis

Tests whole-body electrical muscle stimulation exercise in adults with generalized myasthenia gravis.

Key facts

Who runs it
University of Missouri-Columbia
Where
Columbia and Fairway, United StatesSee the 2 sites
Trial code
Registry title
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
Status
Recruiting
People taking part
16 people, planned
Started
12 Jul 2023
Planned end
Aug 2025
Type of study
Interventional
Treatments tested
  • Whole-body Electrical Muscle Stimulation Exercise
Record updated
10 April 2025

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with generalized myasthenia gravis who tire easily and are on stable treatment. Healthy adults aged 18-39 can also join for one test session.

Age
18 years or older for people with myasthenia gravis; 18-39 years for healthy controls.
Sex
Men and women can join.
Disease stage
Generalized myasthenia gravis with mild or moderate fatigability on the arm and leg outstretched tests of the QMG, and at least some anti-gravity strength (2+/5 or better).
Earlier treatment
Must have been on stable myasthenia gravis therapy for at least 1 month. No regular strength training (2 times per week or more) in the past 6 months.
Biomarker or test result
Positive test for acetylcholine receptor (AChR) antibodies, or a negative test with symptoms consistent with generalized myasthenia gravis.

Main reasons for not taking part

  • Taking part in another interventional research study
  • Pacemaker, metal implants or other implanted medical devices
  • Unstable acute or chronic disease, or a terminal disease
  • Known pregnancy at screening
  • Another neuromuscular or neurologic condition, such as Parkinson's disease or stroke

The registry criteria, word for word

Show all 30 criteriaShow less

Who can take part

  • Age 18 or older
  • Diagnosed with Generalized Myasthenia Gravis (gMG) via seropositive test for acetylcholine receptor (AChR) antibodies or seronegative test with clinical symptoms consistent with gMG
  • On stable MG therapy for at least 1 month
  • Ability to stand for approximately 15 minutes continuously with or without an assistive device (i.e. the length of time to stand to take a shower, complete meal preparation, wait in line at the bank, etc.)
  • Score of 1 (Mild) or 2 (Moderate) on at least one side of the "arm outstretched" and "leg outstretched" items of the QMG, demonstrating fatigability
  • At least some anti-gravity strength in major muscle groups as assessed by manual muscle testing (i.e. 2+/5 strength or better)
  • Medical clearance to participate in an exercise program
  • Ability to provide informed consent
  • Ability to conform to the requirements of the study (i.e. attendance at assessment and intervention visits, maintain current level of non-study physical activity for the duration of the study, no intention to relocate mid-study)
  • Age 18-39 years
  • Ability to provide informed consent

Who cannot take part

  • Concurrent participation in another interventional research study
  • Presence of a pacemaker, metal implants, or other implanted medical devices that could impact participant safety during WB-EMS intervention
  • Presence of a terminal disease (i.e. receiving hospice services)
  • Current or previous use of any drugs known to influence muscle mass or performance within 6 months; these may include but are not limited to anabolic steroids, IGF01, growth hormone, replacement androgen therapy, anti-androgen therapy
  • Concurrent participation in an interventional research study
  • Presence of a terminal disease (i.e. receiving hospice services)
  • Current or previous use of any drugs known to influence muscle mass or performance within 6 months; these may include but are not limited to anabolic steroids, IGF01, growth hormone, replacement androgen therapy, anti-androgen therapy
  • Presence of unstable acute or chronic disease (i.e. renal failure, rheumatologic disease, cardia arrhythmia, neoplasm, uncontrolled hypertension)
  • Presence of an additional neuromuscular or neurologic condition affecting somatosensory or motor function/control (i.e. motor neuron disease, muscle disease, peripheral neuropathy, other NMJ condition, Parkinson's disease, Multiple Sclerosis, h/o stroke, traumatic brain injury, spinal cord injury, ataxia, apraxia, hemiplegia, etc.)
  • Musculoskeletal condition or surgery in the past year that would confound results of exercise interventions (i.e. knee replacement, hip replacement, rotator cuff repair, spinal fusion)
  • Other medical conditions, signs, or symptoms that would interfere with study conduct or interpretation of results as determined by an investigator
  • Presence of unstable acute or chronic disease (i.e. renal failure, rheumatologic disease, cardia arrhythmia, neoplasm, uncontrolled hypertension)
  • Presence of an additional neuromuscular or neurologic condition affecting somatosensory or motor function/control (i.e. motor neuron disease, muscle disease, peripheral neuropathy, other NMJ condition, Parkinson's disease, Multiple Sclerosis, h/o stroke, TBI, SCI, ataxia, apraxia, hemiplegia, etc.)
  • Musculoskeletal condition or surgery in the past year that would confound results of exercise interventions (i.e. TKA, THA, RTC repair, spinal fusion)
  • Other medical conditions, signs, or symptoms that would interfere with study conduct or interpretation of results as determined by an investigator; Healthy controls will complete dEMG testing only during a one-time session
  • Unable to tolerate 15 minutes of continuous standing with or without an assistive device
  • Regular participation in strength training (2x per week or more over the past 6 months)
  • Score of 0 (None) on all "arm outstretched" and "leg outstretched" items of the QMG
  • Known pregnancy at time of screening

Where in United States

  • NextGen Precision Health Building, Clinical and Translational Science UnitColumbia, United StatesContact: Manny MoralesTaking people
  • University of Kansas Clinical Research CenterFairway, United StatesContact: Fairway Clinical and Translational Research UnitTaking people

About the trial

What the trial wants to find out

During this pilot study, the investigators will examine the effects of whole-body electrical muscle stimulation exercise (WB-EMS Exercise) on neuromuscular junction (NMJ) transmission and fatigability in adults with Generalized Myasthenia Gravis (gMG). The investigators will also test whether a relationship exists between NMJ transmission dysfunction and fatigability in gMG, which has long been presumed but never directly assessed. Participants will undergo clinical and electrophysiologic testing before and after the WB-EMS Exercise intervention. The WB-EMS Exercise intervention will be delivered 2 times per week for 4 weeks. Long-term follow up is optional. The hypotheses are (a) that the WB-EMS exercise will improve fatigability and NMJ transmission, and (b) that NMJ transmission dysfunction is related to fatigability.

The group in the trial

  • Whole-body Electrical Muscle Stimulation (WB-EMS) ExerciseTreatment being tested

    Participants with MG will receive the WB-EMS Exercise intervention 2 times per week for 4 weeks. Participants will only perform Level 1 exercise programs (simple movements) in the "Strength" Training Mode. These programs are 20-minute videos led by exercise professionals. They are full-body workouts. They consist of 10-12 exercises performed for 14 repetitions. Each repetition takes 4 seconds to complete (the time that the stimulation is "on") and is followed by a 4 second rest (the time that the stimulation is "off"). All exercises occur in a double-limb stance position. Most exercises occur with feet in wide base of support, hips width or more apart. All exercises are modifiable by the healthcare professional administering and monitoring the intervention based on participant's safe and available range of motion (i.e. arm movements, torso positions, extent of knee bend). Healthy Control participants will not complete the intervention.

    Treatment: Whole-body Electrical Muscle Stimulation Exercise

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effects of Whole-body Electrical Muscle Stimulation Exercise on Adults With Myasthenia Gravis
Plain-language title
Electrical muscle stimulation exercise studied in adults with myasthenia gravisGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Record updated
10 April 2025